Search research articles
Contact Us
Filters
Showing results (11-20 of 156) with videos related to
Page
of 16
Sort By:
Drug Discovery Today. Therapeutic Strategies
|
April 20, 2013
When one skeleton is enough: approaches and strategies for the treatment of fibrodysplasia ossificans progressiva (FOP)
Frederick S Kaplan, Jay Groppe, Eileen M Shore
Biomolecules
|
February 24, 2024
The HIF-1α and mTOR Pathways Amplify Heterotopic Ossification
Haitao Wang, Frederick S Kaplan, Robert J Pignolo
Journal of Orthopaedic Trauma
|
December 31, 2003
Body mass and fracture risk: a study of 330 patients. 1999
Joseph Bernstein, Jeane Ann Grisso, Frederick S Kaplan
Seminars in Cell & Developmental Biology
|
December 27, 2015
Granting immunity to FOP and catching heterotopic ossification in the Act
Frederick S Kaplan, Robert J Pignolo, Eileen M Shore
Frontiers in Cell and Developmental Biology
|
December 28, 2020
The Developmental Phenotype of the Great Toe in Fibrodysplasia Ossificans Progressiva
O Will Towler, Frederick S Kaplan, Eileen M Shore
Bone
|
June 11, 2017
Longitudinal patient-reported mobility assessment in fibrodysplasia ossificans progressiva (FOP)
Frederick S Kaplan, Mona Al Mukaddam, Robert J Pignolo
Clinical Orthopaedics and Related Research
|
June 19, 2007
Functional modeling of the ACVR1 (R206H) mutation in FOP
Jay C Groppe, Eileen M Shore, Frederick S Kaplan
Cytokine & Growth Factor Reviews
|
November 10, 2009
The FOP metamorphogene encodes a novel type I receptor that dysregulates BMP signaling
Frederick S Kaplan, Robert J Pignolo, Eileen M Shore
Bone
|
March 24, 2018
Heterotopic Ossification: The Keys to the Kingdom
Frederick S Kaplan, Robert J Pignolo, Eileen M Shore
Expert Opinion on Orphan Drugs
|
May 7, 2014
From mysteries to medicines: drug development for fibrodysplasia ossificans progressive
Frederick S Kaplan, Robert J Pignolo, Eileen M Shore
Page
of 16
Search research articles
Search
Showing results (11-20 of 156) with videos related to
Sort By:
Page
of 16
Drug Discovery Today. Therapeutic Strategies
|
April 20, 2013
When one skeleton is enough: approaches and strategies for the treatment of fibrodysplasia ossificans progressiva (FOP)
Frederick S Kaplan, Jay Groppe, Eileen M Shore
Biomolecules
|
February 24, 2024
The HIF-1α and mTOR Pathways Amplify Heterotopic Ossification
Haitao Wang, Frederick S Kaplan, Robert J Pignolo
Journal of Orthopaedic Trauma
|
December 31, 2003
Body mass and fracture risk: a study of 330 patients. 1999
Joseph Bernstein, Jeane Ann Grisso, Frederick S Kaplan
Seminars in Cell & Developmental Biology
|
December 27, 2015
Granting immunity to FOP and catching heterotopic ossification in the Act
Frederick S Kaplan, Robert J Pignolo, Eileen M Shore
Frontiers in Cell and Developmental Biology
|
December 28, 2020
The Developmental Phenotype of the Great Toe in Fibrodysplasia Ossificans Progressiva
O Will Towler, Frederick S Kaplan, Eileen M Shore
Bone
|
June 11, 2017
Longitudinal patient-reported mobility assessment in fibrodysplasia ossificans progressiva (FOP)
Frederick S Kaplan, Mona Al Mukaddam, Robert J Pignolo
Clinical Orthopaedics and Related Research
|
June 19, 2007
Functional modeling of the ACVR1 (R206H) mutation in FOP
Jay C Groppe, Eileen M Shore, Frederick S Kaplan
Cytokine & Growth Factor Reviews
|
November 10, 2009
The FOP metamorphogene encodes a novel type I receptor that dysregulates BMP signaling
Frederick S Kaplan, Robert J Pignolo, Eileen M Shore
Bone
|
March 24, 2018
Heterotopic Ossification: The Keys to the Kingdom
Frederick S Kaplan, Robert J Pignolo, Eileen M Shore
Expert Opinion on Orphan Drugs
|
May 7, 2014
From mysteries to medicines: drug development for fibrodysplasia ossificans progressive
Frederick S Kaplan, Robert J Pignolo, Eileen M Shore
Page
of 16